<?xml version="1.0" encoding="UTF-8"?>
<ref id="B182">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pardi</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Parkhouse</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kirkpatrick</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>McMahon</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Zost</surname>
    <given-names>S. J.</given-names>
   </name>
   <name>
    <surname>Mui</surname>
    <given-names>B. L.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2018b</year>). 
  <article-title>Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies</article-title>. 
  <source>Nat. Commun.</source>
  <volume>9</volume>:
  <fpage>3361</fpage>. 
  <pub-id pub-id-type="doi">10.1038/s41467-018-05482-0</pub-id>
  <?supplied-pmid 30135514?>
  <pub-id pub-id-type="pmid">30135514</pub-id>
 </mixed-citation>
</ref>
